Cassava sciences to present at the jefferies global healthcare conference

Austin, texas, june 01, 2023 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, today announced that its management has been invited to present at the jefferies global healthcare conference in new york city.

SAVA Ratings Summary

SAVA Quant Ranking